EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disorders

Alexandros Giannakis, Spiridon Konitsiotis, Chrissa Sioka

Journal of Neural Transmission · 2026-05 · 133 (5) · 843-852

DOI: 10.1007/s00702-025-02955-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neural Transmission, online erschienen am 30.05.2025. Verfasst von Alexandros Giannakis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital of Ioannina, 1 Stavrou Niarchou Av, Ioannina, 45500, Greece. papadates@gmail.com. Hauptthemen laut MEDLINE: Biomarkers, Supranuclear Palsy, Progressive, Corticobasal Degeneration, Neurodegenerative Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This narrative review evaluates the diagnostic potential of serum biomarkers for progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and related neurodegenerative diseases. Hyperphosphorylated tau species (p-tau), particularly p-tau217 and p-tau181, show promise in distinguishing PSP and CBS from other neurodegenerative diseases, though not from each other. While serum neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) exhibit limited individual utility, their combination with p-tau species enhances diagnostic accuracy. Other genome-associated, inflammatory, metabolic biomarkers, and neuropeptides yield interesting though inconsistent results. The majority of serum biomarkers yielded non-specific results in differentiating PSP and/or CBS from each other and from other related neurodegenerative diseases. Future large-scale, multi-center studies with autopsy confirmation in early-stage patients are essential for developing reliable biomarker panels. Direct comparative studies of PSP and CBS subtypes are also necessary for accurate phenotypic discrimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersSupranuclear Palsy, ProgressiveCorticobasal DegenerationNeurodegenerative DiseasesBasal Ganglia DiseasesHumanstau Proteins

Stichwörter der Autor:innen

BiomarkerCorticobasal syndromeNeurodegenerative diseaseProgressive supranuclear palsySerum

Substanzen

Biomarkerstau Proteins

Autor:innen und Institutionen

  • Department of Neurology, University Hospital of Ioannina, 1 Stavrou Niarchou Av, Ioannina, 45500, Greece. papadates@gmail.com.
  • Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Ioannina, 45500, Greece.
  • Department of Nuclear Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Ioannina, 45500, Greece.

Zitieren

APA

Giannakis, A., Konitsiotis, S., & Sioka, C. (2026). A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disorders. Journal of Neural Transmission, 133(5), 843-852. https://doi.org/10.1007/s00702-025-02955-7

Vancouver

Giannakis A, Konitsiotis S, Sioka C. A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disorders. Journal of Neural Transmission. 2026;133(5):843-852. doi:10.1007/s00702-025-02955-7

BibTeX
@article{Giannakis2026,
  author = {Giannakis, Alexandros and Konitsiotis, Spiridon and Sioka, Chrissa},
  title = {A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disorders},
  journal = {Journal of Neural Transmission},
  year = {2026},
  volume = {133},
  number = {5},
  pages = {843--852},
  doi = {10.1007/s00702-025-02955-7}
}
Kostenlos starten →